放出制御ドラッグデリバリー市場：放出メカニズム、技術、用途別-2025-2030年世界予測

放出制御ドラッグデリバリー市場は、2023年に430億7,000万米ドルと評価され、2024年には467億米ドルに達すると予測され、CAGR 9.17％で成長し、2030年には796億2,000万米ドルに達すると予測されています。

放出制御ドラッグデリバリーシステムは、治療効果を高めるために、医薬品有効成分を所定の速度、位置、持続時間で体内に放出するように設計された高度なメカニズムです。この領域は、副作用を最小限に抑えながら薬効を高めるものであり、経口剤、経皮剤、注射剤、眼科治療など、さまざまな医薬品用途で有用です。精密医療への注目が高まる中、このようなシステムの必要性は、臨床上の利益と患者のコンプライアンスを最大化することにあり、慢性疾患の管理、高齢者医療、一貫した投薬レベルを必要とする疾患にとって不可欠なものとなっています。

同市場の成長を牽引しているのは、技術の進歩、慢性疾患の有病率の上昇、研究開発投資の増加です。生物製剤とバイオシミラーも、高度な送達システムの必要性を高めています。成長に影響を与える主な要因としては、ナノテクノロジーの統合、ポリマー科学の進歩、バイオアベイラビリティの向上などが挙げられます。市場関係者にとっては、生分解性ポリマー、遠隔ドラッグデリバリーシステム、マイクロカプセル化技術の探求にビジネスチャンスがあります。より優れた患者教育ツールの開拓と服薬アドヒアランスの確保も、市場浸透の新たな道を開く可能性があります。

しかし、厳しい規制要件、高い初期開発コスト、複雑な薬物放出メカニズムなどの課題が大きな障壁となっています。生体適合性の問題への対処や、予期せぬ全身的な放出エラーの管理は、依然として重要な課題です。利害関係者は、先端材料科学、AIを活用した個別化医療ソリューション、バイオ製薬企業とヘルスケア分析企業のコラボレーションに注力することで、イノベーションを活用することができます。さらに、環境的に持続可能な手法を開発することで、競争上の優位性を得ることができます。ヘルスケアへのアクセスやインフラが急速に改善しつつあるアジア太平洋やラテンアメリカの新興市場に戦略的に重点を置くことも、大きなリターンをもたらす可能性があります。市場の競争は激しく、かつ細分化されているため、既存プレーヤーにも、技術的進歩を活用して拡大するヘルスケア需要に対応する新興企業にも大きなビジネスチャンスがあります。

市場力学：急速に進化する放出制御ドラッグデリバリー市場の主要市場インサイトを公開

放出制御ドラッグデリバリー市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 乳幼児および高齢者向けの放出制御剤形に対するニーズの増加
  • ハイドロゲルおよび浸透圧制御ドラッグデリバリーシステムの採用増加
  • 様々な種類の病気をコントロールするための治療効果の向上、薬物毒性の低減の必要性
• 市場抑制要因
  • 放出制御ドラッグデリバリーシステムの複雑な製造工程
• 市場機会
  • 放出制御ドラッグデリバリーシステムのための先端医療／薬物製剤におけるナノテクノロジーの発展の可能性
  • 放出制御ドラッグデリバリーシステムの進歩
• 市場の課題
  • 薬物放出制御製剤の潜在的限界

ポーターの5つの力：放出制御ドラッグデリバリー市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：放出制御ドラッグデリバリー市場における外部からの影響の把握

外部マクロ環境要因は、放出制御ドラッグデリバリー市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析放出制御ドラッグデリバリー市場における競合情勢の把握

放出制御ドラッグデリバリー市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス放出制御ドラッグデリバリー市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、放出制御ドラッグデリバリー市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 乳幼児および高齢者層における放出制御製剤のニーズ増加
    • ハイドロゲルと浸透圧制御ドラッグデリバリーシステムの採用増加
    • さまざまな病気を制御するために治療効果を高め、薬物の毒性を減らす必要がある
  • 抑制要因
    • 放出制御ドラッグデリバリーシステムの複雑な製造プロセス
  • 機会
    • 先端医療におけるナノテクノロジーの潜在的開発/放出制御型ドラッグデリバリーシステムのための製剤
    • 制御放出ドラッグデリバリーシステムの進歩
  • 課題
    • 制御薬物放出製剤の潜在的な限界
• 市場セグメンテーション分析
  • 放出メカニズム：化学的に活性化された堅牢なシステムの開発に向けた研究開発活動の強化
  • 技術：治療指数を高め、副作用を軽減するための標的送達の統合
  • 応用：慢性疾患管理における注射可能な徐放性ドラッグデリバリーシステムの好感度の高まり
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境
• 顧客のカスタマイズ

第6章 放出制御ドラッグデリバリー市場リリースメカニズム別

• 活性化変調ドラッグデリバリーシステム
  • 流体圧力活性化
  • 磁気活性化
  • 機械的に作動
  • 浸透圧活性化
  • 蒸気圧活性化
• 化学的に活性化
  • 酵素活性化
  • 加水分解活性化
  • pH活性化
• フィードバック制御ドラッグデリバリーシステム
• マイクロリザーバーパーティション制御ドラッグデリバリーシステム
• ポリマーベースのシステム

第7章 放出制御ドラッグデリバリー市場：技術別

• コアセルベーション
• インプラント
• マイクロカプセル化
• ターゲット配信
• 経皮
• ウルスターテクニック

第8章 放出制御ドラッグデリバリー市場：用途別

• 薬剤溶出ステント
• 輸液ポンプ
• 注射可能
• 定量吸入器
• 経口制御ドラッグデリバリーシステム
• 経皮パッチと眼科用パッチ

第9章 南北アメリカの放出制御ドラッグデリバリー市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の放出制御ドラッグデリバリー市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの放出制御ドラッグデリバリー市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • DelSiTech、シリカベースのドラッグデリバリー技術プラットフォームの発展に向けて1,000万ユーロの資金調達ラウンドの完了を発表
  • Chiesi Global Rare DiseasesとAliada Therapeuticsが提携し、ドラッグデリバリーのための血液脳関門通過プラットフォーム技術を発展させる

企業一覧

• Tandem Diabetes Care, Inc.
• Johnson & Johnson Services, Inc.
• Insulet Corporation
• Merck & Co., Inc.
• Alkermes PLC
• GlaxoSmithKline PLC
• Becton, Dickinson and Company
• Pensatech Pharma GmbH
• Celares GmbH
• Trelleborg AB
• Lonza Group Ltd.
• Celanese Corporation
• Boehringer Ingelheim International GmbH
• CURE Pharmaceutical
• Baxter International Inc.
• Medtronic PLC
• Colorcon, Inc.
• Adare Pharma Solutions
• Collegium Pharmaceutical, Inc.
• Pfizer Inc.
• Catalent, Inc.
• Avantor, Inc.
• Corium, Inc.
• AMW GmbH
• Seqens
• Biogen Inc.
• Coating Place, Inc.
• AstraZeneca PLC

LIST OF FIGURES

• FIGURE 1. CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH PROCESS
• FIGURE 2. CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. CONTROLLED RELEASE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. CONTROLLED RELEASE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CONTROLLED RELEASE DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CONTROLLED RELEASE DRUG DELIVERY MARKET DYNAMICS
• TABLE 7. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDRODYNAMIC PRESSURE ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MAGNETICALLY ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MECHANICALLY ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY OSMOTIC PRESSURE ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY VAPOR PRESSURE ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ENZYME ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDROLYSIS ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PH ACTIVATED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY FEEDBACK REGULATED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO RESERVOIR PARTITION CONTROLLED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER BASED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COACERVATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO ENCAPSULATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY WURSTER TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ORAL CONTROLLED-DRUG DELIVERY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL & OCULAR PATCHES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 54. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 55. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 56. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 81. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 82. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 83. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 86. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 87. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 88. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 91. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 96. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 97. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 101. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 102. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 103. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 106. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 107. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 108. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 111. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 112. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 113. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 116. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 117. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 118. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 121. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 122. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 123. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 126. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 127. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 128. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 129. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 131. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 132. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 133. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 136. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 137. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 138. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 141. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 142. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 143. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 144. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 145. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. EGYPT CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 147. EGYPT CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 148. EGYPT CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 149. EGYPT CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 150. EGYPT CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. FINLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 152. FINLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 153. FINLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 154. FINLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. FINLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 157. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 158. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 159. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 160. FRANCE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 162. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 163. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 164. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 165. GERMANY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. ISRAEL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 167. ISRAEL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 168. ISRAEL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 169. ISRAEL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 170. ISRAEL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 172. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 173. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 174. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. ITALY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. NETHERLANDS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 177. NETHERLANDS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 178. NETHERLANDS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 179. NETHERLANDS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 180. NETHERLANDS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. NIGERIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 182. NIGERIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 183. NIGERIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 184. NIGERIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 185. NIGERIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. NORWAY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 187. NORWAY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 188. NORWAY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 189. NORWAY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 190. NORWAY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. POLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 192. POLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 193. POLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 194. POLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 195. POLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. QATAR CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 197. QATAR CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 198. QATAR CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 199. QATAR CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 200. QATAR CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 202. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 203. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 204. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 205. RUSSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 206. SAUDI ARABIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 207. SAUDI ARABIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 208. SAUDI ARABIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 209. SAUDI ARABIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 210. SAUDI ARABIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. SOUTH AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 212. SOUTH AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 213. SOUTH AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 214. SOUTH AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 215. SOUTH AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 217. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 218. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 219. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 220. SPAIN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 221. SWEDEN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 222. SWEDEN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 223. SWEDEN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 224. SWEDEN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 225. SWEDEN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. SWITZERLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 227. SWITZERLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 228. SWITZERLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 229. SWITZERLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 230. SWITZERLAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. TURKEY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 232. TURKEY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 233. TURKEY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 234. TURKEY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 235. TURKEY CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 236. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 237. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 238. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 239. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 240. UNITED ARAB EMIRATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 241. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2030 (USD MILLION)
• TABLE 242. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2030 (USD MILLION)
• TABLE 243. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2030 (USD MILLION)
• TABLE 244. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 245. UNITED KINGDOM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 246. CONTROLLED RELEASE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 247. CONTROLLED RELEASE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023

The Controlled Release Drug Delivery Market was valued at USD 43.07 billion in 2023, expected to reach USD 46.70 billion in 2024, and is projected to grow at a CAGR of 9.17%, to USD 79.62 billion by 2030.

Controlled release drug delivery systems are sophisticated mechanisms engineered to release active pharmaceutical ingredients into the body at predetermined rates, locations, and durations to enhance therapeutic outcomes. This domain enhances drug efficacy while minimizing side effects, making it invaluable across various pharmaceutical applications, including oral, transdermal, injectables, and ocular therapies. With increased focus on precision medicine, the necessity of such systems lies in maximizing clinical benefits and patient compliance, proving essential for chronic disease management, geriatric care, and conditions requiring consistent medication levels.

The market's growth is driven by technological advancements, rising prevalence of chronic diseases, and increasing R&D investments, spurred by an aging global population and the demand for improved patient-centric therapies. Biologics and biosimilars also bolster the need for advanced delivery systems. Key influencing growth factors include the integration of nanotechnology, polymer science advancements, and enhanced bioavailability applications. Opportunities for market players lie in exploring biodegradable polymers, remote drug delivery systems, and microencapsulation techniques. Developing better patient education tools and ensuring adherence can also open new avenues for market penetration.

However, challenges such as stringent regulatory requirements, high initial development costs, and complex drug release mechanisms pose significant barriers. Addressing biocompatibility issues and managing unexpected systemic release errors remain critical challenges. Stakeholders can capitalize on innovation by focusing on advanced material sciences, AI-driven personalized medicine solutions, and collaborations between biopharma companies and healthcare analytics firms. Additionally, developing environmentally sustainable practices can offer competitive advantages. A strategic emphasis on emerging markets in Asia-Pacific and Latin America, where healthcare access and infrastructure are improving rapidly, could also yield substantial returns. The nature of the market is competitive yet fragmented, with significant opportunities for both established players and startups that leverage technological advancements to meet growing healthcare demands.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Controlled Release Drug Delivery Market

The Controlled Release Drug Delivery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase in Need for Controlled Release Dosage Forms for the Infants and Geriatric Population
  • Rising Adoption of Hydrogel and Osmotic Controlled Drug Delivery System
  • Need to Improve the Therapeutic Benefits, Reduce Drug Toxicity to Control Various Types of Illness
• Market Restraints
  • Complex Manufacturing Process of Controlled Release Drug Delivery System
• Market Opportunities
  • Potential Development of Nanotechnology in Advanced Medicine/Drug Formulations for Controlled-Release Drug Delivery System
  • Advances in Control Release Drug Delivery System
• Market Challenges
  • Potential limitation of controlled drug release formulation

Porter's Five Forces: A Strategic Tool for Navigating the Controlled Release Drug Delivery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Controlled Release Drug Delivery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Controlled Release Drug Delivery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Controlled Release Drug Delivery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Controlled Release Drug Delivery Market

A detailed market share analysis in the Controlled Release Drug Delivery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Controlled Release Drug Delivery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Controlled Release Drug Delivery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Controlled Release Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include Tandem Diabetes Care, Inc., Johnson & Johnson Services, Inc., Insulet Corporation, Merck & Co., Inc., Alkermes PLC, GlaxoSmithKline PLC, Becton, Dickinson and Company, Pensatech Pharma GmbH, Celares GmbH, Trelleborg AB, Lonza Group Ltd., Celanese Corporation, Boehringer Ingelheim International GmbH, CURE Pharmaceutical, Baxter International Inc., Medtronic PLC, Colorcon, Inc., Adare Pharma Solutions, Collegium Pharmaceutical, Inc., Pfizer Inc., Catalent, Inc., Avantor, Inc., Corium, Inc., AMW GmbH, Seqens, Biogen Inc., Coating Place, Inc., and AstraZeneca PLC.

Market Segmentation & Coverage

This research report categorizes the Controlled Release Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Release Mechanism, market is studied across Activation-Modulated Drug Delivery Systems, Chemically Activated, Feedback Regulated Drug Delivery Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, and Polymer Based Systems. The Activation-Modulated Drug Delivery Systems is further studied across Hydrodynamic Pressure Activated, Magnetically Activated, Mechanically Activated, Osmotic Pressure Activated, and Vapor Pressure Activated. The Chemically Activated is further studied across Enzyme Activated, Hydrolysis Activated, and pH Activated.
• Based on Technology, market is studied across Coacervation, Implants, Micro Encapsulation, Targeted Delivery, Transdermal, and Wurster Technique.
• Based on Application, market is studied across Drug Eluting Stents, Infusion Pumps, Injectable, Metered Dose Inhalers, Oral Controlled-Drug Delivery Systems, and Transdermal & Ocular Patches.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in Need for Controlled Release Dosage Forms for the Infants and Geriatric Population
    • 5.1.1.2. Rising Adoption of Hydrogel and Osmotic Controlled Drug Delivery System
    • 5.1.1.3. Need to Improve the Therapeutic Benefits, Reduce Drug Toxicity to Control Various Types of Illness
  • 5.1.2. Restraints
    • 5.1.2.1. Complex Manufacturing Process of Controlled Release Drug Delivery System
  • 5.1.3. Opportunities
    • 5.1.3.1. Potential Development of Nanotechnology in Advanced Medicine/Drug Formulations for Controlled-Release Drug Delivery System
    • 5.1.3.2. Advances in Control Release Drug Delivery System
  • 5.1.4. Challenges
    • 5.1.4.1. Potential limitation of controlled drug release formulation
• 5.2. Market Segmentation Analysis
  • 5.2.1. Release Mechanism: Increasing R&D activities for development of robust chemically activated system
  • 5.2.2. Technology: Integration of targeted delivery to increase therapeutic index and reducing side effects
  • 5.2.3. Application: Rising preference for injectable controlled-release drug delivery systems for chronic disease management
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Controlled Release Drug Delivery Market, by Release Mechanism

• 6.1. Introduction
• 6.2. Activation-Modulated Drug Delivery Systems
  • 6.2.1. Hydrodynamic Pressure Activated
  • 6.2.2. Magnetically Activated
  • 6.2.3. Mechanically Activated
  • 6.2.4. Osmotic Pressure Activated
  • 6.2.5. Vapor Pressure Activated
• 6.3. Chemically Activated
  • 6.3.1. Enzyme Activated
  • 6.3.2. Hydrolysis Activated
  • 6.3.3. pH Activated
• 6.4. Feedback Regulated Drug Delivery Systems
• 6.5. Micro Reservoir Partition Controlled Drug Delivery Systems
• 6.6. Polymer Based Systems

7. Controlled Release Drug Delivery Market, by Technology

• 7.1. Introduction
• 7.2. Coacervation
• 7.3. Implants
• 7.4. Micro Encapsulation
• 7.5. Targeted Delivery
• 7.6. Transdermal
• 7.7. Wurster Technique

8. Controlled Release Drug Delivery Market, by Application

• 8.1. Introduction
• 8.2. Drug Eluting Stents
• 8.3. Infusion Pumps
• 8.4. Injectable
• 8.5. Metered Dose Inhalers
• 8.6. Oral Controlled-Drug Delivery Systems
• 8.7. Transdermal & Ocular Patches

9. Americas Controlled Release Drug Delivery Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Controlled Release Drug Delivery Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Controlled Release Drug Delivery Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. DelSiTech Announces Closing of EUR 10 Million Financing Round to Advance its Silica-Based Drug Delivery Technology Platform
  • 12.3.2. Chiesi Global Rare Diseases and Aliada Therapeutics Partner to Advance Blood-Brain Barrier-Crossing Platform Technology for Drug Delivery

Companies Mentioned

• 1. Tandem Diabetes Care, Inc.
• 2. Johnson & Johnson Services, Inc.
• 3. Insulet Corporation
• 4. Merck & Co., Inc.
• 5. Alkermes PLC
• 6. GlaxoSmithKline PLC
• 7. Becton, Dickinson and Company
• 8. Pensatech Pharma GmbH
• 9. Celares GmbH
• 10. Trelleborg AB
• 11. Lonza Group Ltd.
• 12. Celanese Corporation
• 13. Boehringer Ingelheim International GmbH
• 14. CURE Pharmaceutical
• 15. Baxter International Inc.
• 16. Medtronic PLC
• 17. Colorcon, Inc.
• 18. Adare Pharma Solutions
• 19. Collegium Pharmaceutical, Inc.
• 20. Pfizer Inc.
• 21. Catalent, Inc.
• 22. Avantor, Inc.
• 23. Corium, Inc.
• 24. AMW GmbH
• 25. Seqens
• 26. Biogen Inc.
• 27. Coating Place, Inc.
• 28. AstraZeneca PLC